Telix Pharmaceuticals Limited Cash Flows From Used In Financing Activities
Telix Pharmaceuticals Limited (TLPPF) reported Cash Flows From Used In Financing Activities of -$3.72 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-20.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:CashFlowsFromUsedInFinancingActivities · last filed 2026-02-20
AUD
| Period end | Cash Flows From Used In Financing Activities 12 month |
|---|---|
| 2024-12-31 | 638.92M AUD 20-F · filed 2025-02-24 |
| 2023-12-31 | 10.19M AUD 20-F · filed 2025-02-24 |
| 2022-12-31 | 174.96M AUD 20-F · filed 2025-02-24 |
USD
| Period end | Cash Flows From Used In Financing Activities 12 month |
|---|---|
| 2025-12-31 | -$3.72M 20-F · filed 2026-02-20 |
| 2024-12-31 | $416.79M 20-F · filed 2026-02-20 |
| 2023-12-31 | $7.09M 20-F · filed 2026-02-20 |